MOREPEN LAB. LTD
MOREPENLAB · General/Diversified · NSE
₹42
Current Market Price
Fair Value (DCF)
₹29
Margin of Safety
-31.6%
Updated 2d ago
YieldIQ Score
43/100
Piotroski F-Score
4/9
Economic Moat
Narrow
Confidence
28%
ROE
—
Debt/Equity
0.13
WACC
11.1%
Market Cap
₹2,312 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
12.8%
Return on capital employed
EV / EBITDA
23.3×
Enterprise multiple
Debt / EBITDA
1.0×
Leverage vs earnings
Interest Coverage
20.9×
EBIT covers interest
Current Ratio
2.32×
Short-term liquidity
Asset Turnover
1.01×
Revenue per ₹ of assets
Revenue CAGR (3Y)
5.4%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹42.19
Bear case
₹17.24
MoS -144.7%
Base case
₹28.86
MoS -46.2%
Bull case
₹36.71
MoS -14.9%
Ratio Trends
MOREPENLAB · last 8 annual periods
ROE
9.9%
ROCE
14.9%
Operating Margin
—
Debt / Equity
0.09×
PE
36.5×
EV / EBITDA
16.5×
Historical Financials
MOREPENLAB · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹1188 Cr | ₹1547 Cr | ₹1414 Cr | ₹1682 Cr | ₹1804 Cr | +11.0% |
| EBITDA | — | ₹157 Cr | ₹85.7 Cr | ₹173 Cr | ₹192 Cr | +5.2% |
| EBIT | ₹100 Cr | ₹119 Cr | ₹11.7 Cr | ₹43.0 Cr | — | -19.1% |
| PAT | ₹97.1 Cr | ₹102 Cr | ₹38.7 Cr | ₹96.2 Cr | ₹118 Cr | +5.0% |
| EPS (diluted) | ₹2.15 | ₹1.96 | ₹0.16 | ₹0.54 | — | -29.2% |
| CFO | ₹50.9 Cr | ₹-57.8 Cr | ₹-91.2 Cr | ₹73.4 Cr | ₹32.1 Cr | -10.9% |
| CapEx | — | — | — | — | ₹-214 Cr | — |
| FCF | — | — | — | — | ₹-182 Cr | — |
| Total Assets | — | ₹1070 Cr | ₹1110 Cr | ₹1293 Cr | ₹1778 Cr | +13.5% |
| Total Debt | — | — | ₹24.2 Cr | ₹25.6 Cr | ₹105 Cr | +44.3% |
| Shareholders' Equity | — | — | ₹753 Cr | ₹847 Cr | ₹1187 Cr | +12.1% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
MOREPENLAB vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| HIKAL HIKAL | — | — | Pending | 7.2% | — |
| SOLARA SOLARA ACTIVE PHA SCI LTD | +106.8% | 75 | Below Fair Value | 0.0% | — |
| UNICHEMLAB UNICHEM LABORATORIES LTD | +28.6% | 66 | Below Fair Value | 5.6% | — |
| INDOCO INDOCO | — | — | Pending | -7.2% | — |
| IOLCP IOL CHEM AND PHARMA LTD | -48.3% | 15 | Above Fair Value | 6.0% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for MOREPENLAB in the last 10 years.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. MOREPEN LAB. LTD (MOREPENLAB.NS) trades at 42.19 vs a model fair value of 28.86, a gap of -31.6%. Piotroski F-score: 4/9. Moat label: Nar...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of MOREPENLAB →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for MOREPENLAB →
Compare
Head-to-head with peers
Compare MOREPENLAB side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse MOREPENLABNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.